Baltruškevičienė, E., Mickys, U., Žvirblis, T., Stulpinas, R., Pipirienė Želvienė, T., & Aleknavičius, E. (2016). Significance of KRAS, NRAS, BRAF and PIK3CA mutations in metastatic colorectal cancer patients receiving Bevacizumab: a single institution experience. Acta Medica Lituanica, 23(1), 24-34. https://doi.org/10.6001/actamedica.v23i1.3267